Product type number as specified by the Swiss Structured Products Association (SSPA): 1300
Please consult the termsheet and the accompanying issue prospectus for information on the exact product functionality, product details and risks.
Scenario 1 | Scenario 2 | Scenario 3 | |
---|---|---|---|
Description | Rising underlying | Stagnating underlying | Falling underlying |
Underlying value | 20% share A 20% share B 20% share C 20% D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
Term | 5 years | 5 years | 5 years |
Issue price | CHF 100 | CHF 100 | CHF 100 |
Capital employed | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) |
Basket at initial fixing | CHF 100 | CHF 100 | CHF 100 |
Basket at maturity | CHF 120 | CHF 100 | CHF 80 |
Performance basket | 20% | 0% | -20% |
Scenario 1 | Scenario 2 | Scenario 3 | |
---|---|---|---|
Calculation | 100 Zertifikate * 120 | 100 Zertifikate * 100 | 100 Zertifikate * 80 |
Redemption | CHF 12'000 | CHF 10'000 | CHF 8'000 |
Profit / Loss | 20% | 0% | -20% |
ZKB Tracker-Zertifikat auf einen internationalen Dividendenbasket CHF 113975692 / CH1139756923 |
ZKB Autocallable Barrier Reverse Convertible on worst of Biogen Inc/BioNTech SE/Moderna Inc 132913422 / CH1329134220 |
ZKB Reverse Convertible auf Moderna Inc 135805451 / CH1358054513 |
ZKB Reverse Convertible on worst of BioNTech SE/Moderna Inc/Pfizer Inc 132912820 / CH1329128206 |
ZKB Reverse Convertible on worst of Eli Lilly & Co/Moderna Inc 135805731 / CH1358057318 |